Does Weight Impact Anidulafungin Pharmacokinetics?

Bodyweight has been shown to influence anidulafungin exposure, but data from obese patients are lacking. We determined anidulafungin pharmacokinetics (100-mg single dose) in eight morbidly obese subjects (body mass index >40 kg/m(2)). Anidulafungin exposure was on average 32.5 % lower compared wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacokinet
Main Authors: Lempers, Vincent J., van Rongen, Anne, van Dongen, Eric P., van Ramshorst, Bert, Burger, David M., Aarnoutse, Rob E., Knibbe, Catherijne A., Brüggemann, Roger J.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2016
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021753/
https://ncbi.nlm.nih.gov/pubmed/27142114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-016-0401-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados